The consumer healthcare company currently trades at about 15x earnings multiple, which represents a 9.41% undervaluation ...

Kenvue Inc. hired an executive from Procter & Gamble Co. to help the company get back on track after its biggest product, ...

Robert F. Kennedy Jr. says Tylenol should be used with caution during pregnancy, but solid data linking it to autism is ...

Texas Attorney General Ken Paxton sued the makers of Tylenol, claiming that they deceptively marketed the medication to ...

Fintel reports that on October 29, 2025, Canaccord Genuity downgraded their outlook for Kenvue (NYSE:KVUE) from Buy to Hold. ...

Texas AG Ken Paxton has sued Johnson & Johnson and Kenvue, alleging they hid Tylenol’s pregnancy risks despite no proven ...

(Reuters) -The makers of Tylenol, Johnson & Johnson and Kenvue, were sued on Tuesday by Texas Attorney General Ken Paxton, ...

Kenvue Inc. (NYSE: KVUE) is one of the most buzzing stocks to buy with huge upside potential. On October 24, Deutsche Bank ...

Donald Trump's top health official on Wednesday said evidence does not show that Kenvue's pain medicine Tylenol definitively ...

As the consumer health company battles claims from the Trump administration that its painkiller Tylenol is linked to autism, Kenvue will bring on Halvorson as its next marketing chief.

Health Secretary Robert F. Kennedy Jr. and Medicare Administrator Dr. Mehmet Oz are scheduled to hold a news briefing ...